EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unravelling dialysis‐related dysglycaemia: Longitudinal insights from continuous glucose monitoring

Hellena Hailu Habte-Asres iD, Ayodele Agbabiaka, Roha Rehan, David C Wheeler iD, Miranda Rosenthal

Diabetic Medicine · 04.05.2026

DOI: 10.1111/dme.70344 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, online erschienen am 04.05.2026. Verfasst von Hellena Hailu Habte-Asres und 4 weiteren Autor:innen. Beteiligte Einrichtung: Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To characterise CGM‐derived glycaemic trajectories over 12months in people receiving maintenance haemodialysis, with a particular focus on hypoglycaemia burden and composite glycaemic risk.

Methods

We conducted a longitudinal observational study. CGM data were collected at baseline, 6 and 12 months. Descriptive statistics summarised characteristics. Outcomes included time in range (TIR), time below range (TBR), time above range (TAR), glycaemic variability (GV), hypoglycaemia burden and glycaemic risk index (GRI). Metrics were summarised using means or medians, and changes between timepoints were assessed using paired t ‐tests or Wilcoxon signed‐rank tests.

Results

In 125 participants (mean age 63.7 years; 54.5% men), TIR increased from 51.6% at baseline to 56.6% at 6 months (mean difference 5.09%, 95% CI 1.06 to 9.12; p = 0.014) but was not sustained at 12 months (50.5%; p = 0.568), with a decline between 6 and 12 months (−6.11%, 95% CI −9.03 to −3.19; p < 0.001). TBR remained low, with a small increase between 6 and 12 months (1.61%, 95% CI 0.59–2.64; p = 0.002). TAR and GV were unchanged across timepoints. Hypoglycaemia burden increased over follow‐up ( p < 0.001), while GRI showed no change. HbA1c showed moderate concordance with CGM‐derived glucose at baseline ( ρ = 0.39; p = 0.0001) and 12 months ( ρ = 0.59; p < 0.0001).

Conclusions

CGM revealed evolving glycaemic patterns. Early improvements in TIR were not sustained, hypoglycaemia increased modestly and the overall GRI remained unchanged. These findings support CGM‐informed, individualised diabetes management, prioritising safety and stability.

Schlagwörter

Stichwörter der Autor:innen

CGMContinious glucose mointoringGlycaemic VariabilityGlycaemic risk indexHbA1c

Autor:innen und Institutionen

  • Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, London, UK.
  • Royal Free London NHS Foundation Trust, London, UK.
  • UCL Department of Nephrology, University College London, Royal Free Campus, London, UK.
  • King's College Hospital, London, UK.

ORCID-Profile: Hellena Hailu Habte-Asres, David C Wheeler

Zitieren

APA

Habte-Asres, H. H., Agbabiaka, A., Rehan, R., Wheeler, D. C., & Rosenthal, M. (2026). Unravelling dialysis‐related dysglycaemia: Longitudinal insights from continuous glucose monitoring. Diabetic Medicine. https://doi.org/10.1111/dme.70344

Vancouver

Habte-Asres HH, Agbabiaka A, Rehan R, Wheeler DC, Rosenthal M. Unravelling dialysis‐related dysglycaemia: Longitudinal insights from continuous glucose monitoring. Diabetic Medicine. 2026. doi:10.1111/dme.70344

BibTeX
@article{HabteAsres2026,
  author = {Habte-Asres, Hellena Hailu and Agbabiaka, Ayodele and Rehan, Roha and Wheeler, David C and Rosenthal, Miranda},
  title = {Unravelling dialysis‐related dysglycaemia: Longitudinal insights from continuous glucose monitoring},
  journal = {Diabetic Medicine},
  year = {2026},
  doi = {10.1111/dme.70344}
}
Kostenlos starten →